Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.437,17
0,15%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Apellis Pharmaceuticals Inc (APLS) Apellis Pharmaceuticals Inc (APLS) Notizie

Apellis Pharmaceuticals Inc

APLS
40,40
-0,65 (-1,58%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/6/202422:50EDGAR2Form 8-K - Current report
05/6/202413:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the..
24/5/202416:00GLOBEPositive One-Year Data from Phase 2 Study of Pegcetacoplan..
21/5/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202414:09EDGAR2Form 8-K - Current report
14/5/202414:00GLOBEApellis Pharmaceuticals Refinances Existing Debt with Up to..
09/5/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202423:13EDGAR2Form 144 - Report of proposed sale of securities
07/5/202413:05GLOBEApellis Pharmaceuticals Reports First Quarter 2024 Financial..
07/5/202413:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202413:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the Bank..
01/5/202413:00GLOBEApellis Announces 11 Oral Presentations at the Association..
26/4/202413:15GLOBEApellis Announces Pegcetacoplan MAA Review Has Been Reset to..
23/4/202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on May 7,..
04/4/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01/4/202413:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the 23rd..
11/3/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202412:00GLOBEApellis Appoints Leading Expert Dr. Philip Ferrone as Chief..
08/3/202422:10EDGAR2Form 144 - Report of proposed sale of securities
08/3/202413:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
05/3/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202419:37EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:10EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/2/202413:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202413:30EDGAR2Form 8-K - Current report
27/2/202413:05GLOBEApellis Pharmaceuticals Reports Fourth Quarter and Full Year..
27/2/202413:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202413:00GLOBEApellis Pharmaceuticals to Present at Upcoming Investor..
20/2/202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on February..
14/2/202423:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202421:46EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:43EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:28EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:27EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:22EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:19EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
31/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 40,81 Min: 40,29 Max: 41,78
Chiusura: 41,05

La tua Cronologia

NASDAQ
APLS
Apellis Pharmaceuticals
USOTC
LVWJS
Landa App (GM)
NASDAQ
MOLX
USOTC
NIROF
Sportshero (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network